- Home
- DSWL vs NRXP Comparison
DSWL vs NRXP Comparison
Compare DSWL & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSWL | NRXP |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 63.5M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | DSWL | NRXP |
|---|---|---|
| Price | $3.33 | $2.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $30.50 |
| AVG Volume (30 Days) | 10.0K | ★ 476.5K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | ★ 6.06% | N/A |
| EPS Growth | ★ 20.23 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $65,664,000.00 | $242,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $643.59 |
| P/E Ratio | $4.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.93 | $1.21 |
| 52 Week High | $4.48 | $6.01 |
Technical Indicators
Market Signals| Indicator | DSWL | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 36.42 | 48.18 |
| Support Level | $3.53 | $1.96 |
| Resistance Level | $3.64 | $2.24 |
| Average True Range (ATR) | 0.07 | 0.17 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 0.00 | 59.65 |
Price Performance
Historical ComparisonAbout DSWL Deswell Industries Inc.
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.